Quest Diagnostics profit falls 11% on slow demand for non-COVID testing -Breaking
[ad_1]
© Reuters. FILE PHOTO – This is an illustration of a tube marked “COVID-19 test positive”. It was taken on March 10, 2021. REUTERS/Dado Ruvic/Illustration (Reuters) – U.S. lab Quest Diagnostics Inc announced Thursday a 11% decrease in third-quarter profits due to the spreading of the deadly Delta variant, which weighed heavily on its non-coronavirus business.
From $568 million (or $4.14 per share) a year prior, the net income attributable was $505million or $4.02 per share for the quarter ending Sept. 30.
Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts, buy/sell signal, and quotes. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.
[ad_2]